<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=14591"><dc:title>Neutralizing anti-interferon-[gamma] autoantibodies: an ameliorating factor in COVID-19 infection?</dc:title><dc:creator>Kačar,	Mark	(Avtor)
	</dc:creator><dc:creator>Cortes-Acevedo,	Paulina	(Avtor)
	</dc:creator><dc:creator>Patel,	Vinesh	(Avtor)
	</dc:creator><dc:creator>Carter,	Clive	(Avtor)
	</dc:creator><dc:creator>Hughes,	Pamela	(Avtor)
	</dc:creator><dc:creator>McGann,	Hugh P.	(Avtor)
	</dc:creator><dc:creator>Gkrania-Klotsas,	Effrossyni	(Avtor)
	</dc:creator><dc:creator>Baxendale,	Helen	(Avtor)
	</dc:creator><dc:creator>Barcenas-Morales,	Gabriela	(Avtor)
	</dc:creator><dc:creator>Doffinger,	Rainer	(Avtor)
	</dc:creator><dc:creator>Savic,	Sinisa	(Avtor)
	</dc:creator><dc:subject>SARS-CoV-2</dc:subject><dc:subject>COVID-19</dc:subject><dc:subject>interferon-gamma</dc:subject><dc:subject>respiratory distress syndrome</dc:subject><dc:subject>nontuberculous mycobacteria</dc:subject><dc:subject>macrophage activation syndrome</dc:subject><dc:subject>acute respiratory distress syndrome</dc:subject><dc:publisher>Springer Nature</dc:publisher><dc:date>2021</dc:date><dc:date>2021-11-09 14:56:30</dc:date><dc:type>Neznano</dc:type><dc:identifier>14591</dc:identifier><dc:language>sl</dc:language><dc:rights>(c)The Author(s)</dc:rights></rdf:Description></rdf:RDF>